Merck, the global pharmaceutical and chemical company that developed the osteoporosis drug, Fosamax, has recently lost two cases.   The most recent one – Scheinberg vs. Merck – puts Merck on the hot seat for failing to warn the consumer adequately about the extremely harmful side effects of Fosamax.  To read more about it, check out […]

Continue reading about Osteoporosis News: Merck, Maker of Fosamax, in Trouble!

Kathy on February 9th, 2009

Answer: According to Merck, the pharmaceutical company that manufactures Fosamax, osteoporosis is “a systemic disease characterized by low bone mass and microarchitectural deterioration of bone, with a consequent increase in bone fragility and susceptibility to fracture.” (2001)  The problem with this definition is that a person with high bone density may fracture, while another with […]

Continue reading about Quick Question: What Is Osteoporosis?